Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study - Archive ouverte HAL Access content directly
Journal Articles Multiple Sclerosis Journal Year : 2015

Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study

Marc Debouverie
  • Function : Author
  • PersonId : 762777
  • IdRef : 068986629
S. Vukusic
  • Function : Author
J. de Seze
  • Function : Author
D. Brassat
  • Function : Author
S. Wiertlewski
  • Function : Author
Bruno Brochet
Christine Lebrun-Frenay
Pierre Clavelou
  • Function : Author
Eric Thouvenot
J. -P. Camdessanche
  • Function : Author
Bruno Stankoff
  • Function : Author
A. Al Khedr
  • Function : Author
Philippe Cabre
  • Function : Author
C. Papeix
Eric Berger
  • Function : Author
Olivier Heinzlef
  • Function : Author
T. Debroucker
  • Function : Author
Thibault Moreau
  • Function : Author
O. Gout
  • Function : Author
Bertrand Bourre
  • Function : Author
A. Creange
  • Function : Author
Pierre Labauge
L. Magy
  • Function : Author
Gilles Defer
  • Function : Author
Y. Foucher

Abstract

no abstract
Not file

Dates and versions

hal-01259392 , version 1 (20-01-2016)

Identifiers

  • HAL Id : hal-01259392 , version 1

Cite

D. A. Laplaud, L. Barbin, Chloé Rousseau, N. Jousset, Romain Casey, et al.. Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study. Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.62--63. ⟨hal-01259392⟩
204 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More